Acetazolamide-responsive ataxia

Seminars in Neurology

Volumn 32, Issue 5, 2012, Pages 533-537

  Kotagal, Vikas ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

4 aminopyridine; acetazolamide; autosomal dominant; cerebellum; channelopathy; episodic ataxia

Indexed keywords

4 AMINOPYRIDINE; ACETAZOLAMIDE; CARBAMAZEPINE; ETIRACETAM; PLACEBO;

ARTICLE; ATAXIA; CEREBELLAR ATAXIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSARTHRIA; DYSKINESIA; DYSMETRIA; EATON LAMBERT SYNDROME; EPISODIC ATAXIA TYPE 1; EPISODIC ATAXIA TYPE 2; EPISODIC ATAXIA TYPE 3; EPISODIC ATAXIA TYPE 5; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENOTYPE; HEART PALPITATION; HUMAN; HYPERHIDROSIS; HYPOKALEMIC PERIODIC PARALYSIS; MISSENSE MUTATION; MYOKYMIA; NAUSEA; NEPHROLITHIASIS; NEUROLOGIC EXAMINATION; PARESTHESIA; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; WEAKNESS;

ACETAZOLAMIDE; ATAXIA; CALCIUM CHANNELS; CARBONIC ANHYDRASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84878030163     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0033-1334475     Document Type: Article

References (38)

1. Parker H. L. Periodic ataxia. Collect Papers Mayo Clinic Mayo Found 1946-: 1947; 38 642 645
2. Griggs R. C., Moxley R. T. III, Lafrance R. A., McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology: 1978; 28 12 1259 1264
3. Griggs R. C., Nutt J. G. Episodic ataxias as channelopathies. Ann Neurol: 1995; 37 3 285 287
4. Zasorin N. L., Baloh R. W., Myers L. B. Acetazolamide-responsive episodic ataxia syndrome. Neurology: 1983; 33 9 1212 1214
5. Litt M., Kramer P., Browne D., et al. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet: 1994; 55 4 702 709
6. Browne D. L., Gancher S. T., Nutt J. G., et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet: 1994; 8 2 136 140
7. Kramer P. L., Yue Q., Gancher S. T., et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am J Hum Genet: 1995; 57 1 182 185
8. von Brederlow B., Hahn A. F., Koopman W. J., Ebers G. C., Bulman D. E. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet: 1995; 4 2 279 284
9. Ophoff R. A., Terwindt G. M., Vergouwe M. N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell: 1996; 87 3 543 552
10. Jen J. C., Graves T. D., Hess E. J., Hanna M. G., Griggs R. C., Baloh R. W. CINCH investigators Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain: 2007; 130 Pt 10 2484 2493
11. Browne D. L., Brunt E. R., Griggs R. C., et al. Identification of two new KCNA1 mutations in episodic ataxia/myokymia families. Hum Mol Genet: 1995; 4 9 1671 1672
12. D'Adamo M. C., Hanna M. G., Di Govanni G., et al. Episodic ataxia type 1. GeneReviews 2010Feb9. Available from: http://www.ncbi.nlm.nih.gov/books/ NBK25442/
13. Zuberi S. M., Eunson L. H., Spauschus A., et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain: 1999; 122 Pt 5 817 825
14. Eunson L. H., Rea R., Zuberi S. M., et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol: 2000; 48 4 647 656
15. Kinali M., Jungbluth H., Eunson L. H., et al. Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent episodic ataxia. Neuromuscul Disord: 2004; 14 10 689 693
16. Spacey S. Episodic ataxia type 2. GeneReviews 2003Feb24. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1501/
17. Ducros A., Denier C., Joutel A., et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med: 2001; 345 1 17 24
18. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet: 1997; 15 1 62 69
19. Baloh R. W., Yue Q., Furman J. M., Nelson S. F. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol: 1997; 41 1 8 16
20. Spacey S. D., Materek L. A., Szczygielski B. I., Bird T. D. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol: 2005; 62 2 314 316
21. Vighetto A., Froment J. C., Trillet M., Aimard G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch Neurol: 1988; 45 5 547 549
22. Baloh R. W. Episodic ataxias 1 and 2. Handb Clin Neurol: 2012; 103 595 602
23. Steckley J. L., Ebers G. C., Cader M. Z., McLachlan R. S. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology: 2001; 57 8 1499 1502
24. Cader M. Z., Steckley J. L., Dyment D. A., McLachlan R. S., Ebers G. C. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology: 2005; 65 1 156 158
25. Escayg A., De Waard M., Lee D. D., et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet: 2000; 66 5 1531 1539
26. Damji K. F., Allingham R. R., Pollock S. C., et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol: 1996; 53 4 338 344
27. Jen J. C., Wan J., Palos T. P., Howard B. D., Baloh R. W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology: 2005; 65 4 529 534
28. Jen J. C., Yue Q., Karrim J., Nelson S. F., Baloh R. W. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry: 1998; 65 4 565 568
29. von Brevern M., Ta N., Shankar A., et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache: 2006; 46 7 1136 1141
30. Terwindt G. M., Ophoff R. A., van Eijk R., et al. Dutch Migraine Genetics Research Group Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology: 2001; 56 8 1028 1032
31. Bickler P. E., Litt L., Banville D. L., Severinghaus J. W. Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol: 1988; 65 1 422 427
32. Bain P. G., O'Brien M. D., Keevil S. F., Porter D. A. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol: 1992; 31 2 147 154
33. Sappey-Marinier D., Vighetto A., Peyron R., Broussolle E., Bonmartin A. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol: 1999; 46 2 256 259
34. Strupp M., Zwergal A., Brandt T. Episodic ataxia type 2. Neurotherapeutics: 2007; 4 2 267 273
35. Spacey S. D., Hildebrand M. E., Materek L. A., Bird T. D., Snutch T. P. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol: 2004; 56 2 213 220
36. Jen J., Kim G. W., Baloh R. W. Clinical spectrum of episodic ataxia type 2. Neurology: 2004; 62 1 17 22
37. Strupp M., Kalla R., Claassen J., et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology: 2011; 77 3 269 275
38. Hess E. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology: 2011; 77 22 1996 1997, author reply 1997